BioSpace News Archive

Locate Bio Limited today announces that it has changed its name from Locate Therapeutics Limited and received a new direct investment of £0.5 million from Mercia Technologies PLC (AIM: MERC) (“Mercia”).

Hitachi, Ltd. announced today that its heavy ion beam therapy system(1) has started treatment at Osaka Heavy Ion Therapy Center as of October 16. This marks the first operation of Hitachi’s first heavy ion therapy system.

Myriad Genetics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved BRACAnalysis CDx® to be used by healthcare professionals to identify patients with HER2-negative metastatic breast cancer (mBC) who have a germline BRCA mutation and are eligible for treatment with Pfizer’s PARP (poly ADP ribose polymerase) inhibitor, TALZENNA® (talazoparib).

DeltaTrak® will be featuring two new FlashLink Real-Time Mini Loggers at PMA Fresh Summit 2018, Booth 1562, from October 19 to 20, 2018, at the Orange County Convention Center, Orlando Florida.

Amryt’s lead commercial product now available in all five of the EU’s largest markets

DNAe was named ‘Best Diagnostic Medtech Company’ at the 2018 OBN Awards.

The integrated pharma manufacturing group consolidates its portfolio into four businesses- Capsules, Films & Foils, Engineering and Inspection

Higher dose met primary endpoint, the Overall Neuropathy Limitation Scale (ONLS), with statistical significance (p = 0.008)

Two studies are part of broader effort to take aim at one of the world’s deadliest infections

Endomag has won a prestigious British Business Innovation Award from the Institute of Physics (IOP), presented at the Houses of Parliament in London.